CD96 and glioblastoma: The result, much like that of the OS analysis, indicated higher CD96 expression to be significantly related to a poorer DSS in GBM (HR = 1.31, 95% CI = 1.05–1.64, P = 0.015), LGG (HR = 2.18, 95% CI = 1.78–2.67, P = 6.7e-14), and UVM (HR = 1.30, 95% CI = 1.04–1.61, P = 0.021).